
    
      Volunteers will be randomly assigned to receive the vaccines or matching placebos before
      interrupting their antiretroviral therapy at week 24.

      Dosage:

      Remune(TM) 1 ml i.m.* at weeks 0, 12, and 20; ALVAC 1 ml i.m.* at weeks 8,12, 16, and 20.

      * i.m.: injected in a muscle
    
  